Austar LifesciencesAULSF 49 Days Inventory is 64.40 as of Dec. 2025, which is 11% below its 10-year median of 72.68. GuruFocus rates AULSF with a GF Score™ of 49/100 and a GF Value™ of $0.08 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Austar Lifesciences ranks better than 89.31% on this metric.
The historical rank and industry rank for Austar Lifesciences's Days Inventory or its related term are showing as below:
AULSF'
s Days Inventory Range Over the Past 10 Years
Min: 60.83 Med: 72.68 Max: 93.24
Current: 72.77
During the past 13 years, Austar Lifesciences's highest Days Inventory was 93.24. The lowest was 60.83. And the median was 72.68.
AULSF's Days Inventory is ranked better than 89.31% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs AULSF: 72.77
Austar Lifesciences's Days Inventory
declined
from Dec. 2024 (69.56) to Dec. 2025 (64.40).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Austar Lifesciences's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.83.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Austar Lifesciences's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.29.
Austar Lifesciences (OTCPK:AULSF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Austar Lifesciences's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Austar Lifesciences's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Austar Lifesciences Days Inventory Related Terms
Austar Lifesciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Austar Lifesciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Austar Lifesciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austar Lifesciences Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austar Lifesciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Austar Lifesciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austar Lifesciences (AULSF) has a Days Inventory of 64.40 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Austar Lifesciences and its competitors. This is 11% below median its historical median of 72.68. Over the past decade, Austar Lifesciences' Days Inventory has ranged from 60.83 to 93.24. According to the industry distribution chart, Austar Lifesciences ranks #84 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 10.7%.
Is Austar Lifesciences' Days Inventory too high?
Austar Lifesciences' current Days Inventory of 64.40 is 11% below median its 10-year median of 72.68. Over the past 10 years, this metric has ranged from a low of 60.83 to a high of 93.24. The Medical Devices & Instruments industry median Days Inventory is 179.60. Austar Lifesciences' value of 64.40 is 64.1% below this industry median. Based on the distribution chart, Austar Lifesciences ranks #84 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Austar Lifesciences has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Austar Lifesciences' Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Austar Lifesciences ranks #84 out of 786 companies for Days Inventory. This places Austar Lifesciences in the top 11% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. Austar Lifesciences' value of 64.40 is 64.1% below this benchmark. Historically, Austar Lifesciences' own Days Inventory has ranged from 60.83 to 93.24 over the past decade. While the company's 10-year median is 72.68 vs. the industry median of 179.60, Austar Lifesciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austar Lifesciences's current Days Inventory of 64.40 is 64.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Austar Lifesciences and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austar Lifesciences's current Days Inventory is 64.40, which is 11% below median its own 10-year median of 72.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austar Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Austar Lifesciences (AULSF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.08, compared to a current price of $0.02 — trading 75% below its estimated fair value. The current Days Inventory is 64.40, which is 11% below median its 10-year median of 72.68 and 64.1% below the Medical Devices & Instruments industry median of 179.60. Austar Lifesciences' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Austar Lifesciences (AULSF), the current Days Inventory is 64.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austar Lifesciences (AULSF) Overvalued in 2026?
Based on GuruFocus' analysis, Austar Lifesciences stock appears to be undervalued.
The current stock price of $0.02 is trading 75% below its estimated GF Value™ of $0.08.
GuruFocus considers Austar Lifesciences to be Possible Value Trap.
Key valuation signals for AULSF:
Days Inventory: 64.40 (11% below median its 10-year median of 72.68)
GF Value™: $0.08 vs. price of $0.02 (75% below fair value)
Industry Position: 64.1% below the Medical Devices & Instruments median (#84 of 786)
No single metric tells the full story. See the AULSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austar Lifesciences Ltd is an investment holding company, and its subsidiaries are principally engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipment and consumables in the PRC. Its products include Clean Utility Equipment & Chemical Pharmaceutical Preparation System and others. It has three business segment groups: Integrated Process and Packaging Equipment & Systems (IPS), which generates maximum revenue and combines the original business segments of Liquid and Bioprocess System and Powder and Solid System; Consulting, Digitalization, and Construction; and Life Science Equipment and Consumables. The Group generates maximum revenue from Mainland China.
49GF Score
Get the complete analysis for AULSF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AULSF has been successfully added to your 
